NIH stops study of niacin to prevent heart attacks

May 26, 2011 By LAURAN NEERGAARD , AP Medical Writer

(AP) -- Disappointing news: A drug that raises people's so-called good cholesterol didn't go on to prevent heart attacks.

The National Institutes of Health halted a major study of high-dose niacin, a type of B vitamin, on Thursday because the drug wasn't fighting heart disease after all. It was the latest setback in the quest to harness to fight the bad kind.

LDL cholesterol is the main source of artery clogs. Popular , sold under such names as Zocor and Lipitor, are mainstays in lowering LDL. Yet many statin users still suffer heart attacks. So scientists are testing if adding different kinds of drugs to statins would increase HDL - the good kind that helps prevent blocked arteries - enough to protect the heart.

Explore further: FDA approves hard-to-abuse narcotic painkiller

not rated yet
add to favorites email to friend print save as pdf

Related Stories

New drug produces steep drop in bad cholesterol

Nov 17, 2010

(AP) -- An experimental drug boosted good cholesterol so high and dropped bad cholesterol so low in a study that doctors were stunned and voiced renewed hopes for an entirely new way of preventing heart attacks ...

Gene Mutations Linked to Statin Resistance

Dec 17, 2008

(PhysOrg.com) -- Scientists at Duke University Medical Center have identified genetic mutations that may help explain why some people don't respond very well to statins, drugs taken by millions of Americans to fight high ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments : 0